MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$10.63 +0.31 (+3.00%)
As of: Oct 21, 2026 · 3:45 PM EDT

MoonLake Immunotherapeutics (MLTX) Non-Current Debt (2021 - 2026)

Updated

Analysis

MoonLake Immunotherapeutics (MLTX) Non-Current Debt (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 62.48 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 60.50 Bn
10 MoonLake Immunotherapeutics 782.76 Mn -886.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 24.47 Mn
Mar 31, 2025 73.02 Mn
Mar 31, 2021 -58,063.00
API Access

MoonLake Immunotherapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MLTX&period=max&api_key=YOUR_API_KEY